KUZU, I. Et Al. 2020. Molecular Alterations Obtained by High-Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targeted Therapies. 2nd AMP Europe Congress on Clinical Genomics - Beyond the Somatic Mutation , (Milan, Italy), 35.

KUZU, I., CENGİZ SEVAL, G., YÜKSEL, S., KAYGUSUZ, G., DALVA, K., ÖZCAN, M., ... BEKSAÇ, M.(2020). Molecular Alterations Obtained by High-Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targeted Therapies . 2nd AMP Europe Congress on Clinical Genomics - Beyond the Somatic Mutation (pp.35). Milan, Italy

KUZU, IŞINSU Et Al. "Molecular Alterations Obtained by High-Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targeted Therapies," 2nd AMP Europe Congress on Clinical Genomics - Beyond the Somatic Mutation, Milan, Italy, 2020

KUZU, IŞINSU Et Al. "Molecular Alterations Obtained by High-Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targeted Therapies." 2nd AMP Europe Congress on Clinical Genomics - Beyond the Somatic Mutation , Milan, Italy, pp.35, 2020

KUZU, I. Et Al. (2020) . "Molecular Alterations Obtained by High-Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targeted Therapies." 2nd AMP Europe Congress on Clinical Genomics - Beyond the Somatic Mutation , Milan, Italy, p.35.

@conferencepaper{conferencepaper, author={IŞINSU KUZU Et Al. }, title={Molecular Alterations Obtained by High-Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targeted Therapies}, congress name={2nd AMP Europe Congress on Clinical Genomics - Beyond the Somatic Mutation}, city={Milan}, country={Italy}, year={2020}, pages={35} }